• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Genetic analysis of the 'uveal melanoma' C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line.

作者信息

Yu Xiaoxing, Ambrosini Grazia, Roszik Jason, Eterovic Agda Karina, Stempke-Hale Katherine, Seftor Elisabeth A, Chattopadhyay Chandrani, Grimm Elizabeth, Carvajal Richard D, Hendrix Mary J C, Hodi F Stephen, Schwartz Gary K, Woodman Scott E

机构信息

Department of Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA; Systems Biology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA.

出版信息

Pigment Cell Melanoma Res. 2015 May;28(3):357-9. doi: 10.1111/pcmr.12345. Epub 2015 Mar 23.

DOI:10.1111/pcmr.12345
PMID:25515650
Abstract
摘要

相似文献

1
Genetic analysis of the 'uveal melanoma' C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line.对“葡萄膜黑色素瘤”C918细胞系的基因分析显示，存在非典型BRAF和常见KRAS突变，且单串联重复序列图谱与皮肤黑色素瘤C8161细胞系相同。
Pigment Cell Melanoma Res. 2015 May;28(3):357-9. doi: 10.1111/pcmr.12345. Epub 2015 Mar 23.
2
The RAS-BRAF kinase pathway is not involved in uveal melanoma.RAS-RAF激酶通路不参与葡萄膜黑色素瘤。
Melanoma Res. 2004 Jun;14(3):203-5. doi: 10.1097/01.cmr.0000130006.46885.a0.
3
Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutations.I 期扩展和口服 MEK 抑制剂 RO4987655（CH4987655）在有 RAS-RAF 突变的晚期癌症患者中的药效学研究。
Clin Cancer Res. 2014 Aug 15;20(16):4251-61. doi: 10.1158/1078-0432.CCR-14-0341. Epub 2014 Jun 19.
4
Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.KRAS和BRAF中的伴随突变及剪接变体表明晚期结直肠癌中Ras/Raf信号通路存在复杂的扰动。
Gut. 2009 Sep;58(9):1234-41. doi: 10.1136/gut.2008.159137. Epub 2009 May 26.
5
Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS.丝裂原活化蛋白激酶（MAPK）信号通路的激活在葡萄膜黑色素瘤中是常见事件，尽管它很少通过BRAF或RAS的突变发生。
Br J Cancer. 2005 Jun 6;92(11):2032-8. doi: 10.1038/sj.bjc.6602598.
6
Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma.焦磷酸解反应检测原发性葡萄膜黑色素瘤中的B-RAF突变。
Invest Ophthalmol Vis Sci. 2008 Jan;49(1):23-7. doi: 10.1167/iovs.07-0722.
7
Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing.KRAS 和 BRAF 突变在进行微卫星不稳定性检测的结直肠肿瘤患者队列中的临床效用。
Clin Colorectal Cancer. 2013 Sep;12(3):168-78. doi: 10.1016/j.clcc.2013.04.005. Epub 2013 Jun 14.
8
Lack of BRAF mutations in uveal melanoma.葡萄膜黑色素瘤中缺乏BRAF突变。
Cancer Res. 2003 Sep 15;63(18):5712-5.
9
Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI-H carcinomas.结直肠锯齿状腺癌与传统型和散发性 MSI-H 型结肠癌相比，具有不同的致癌基因突变谱、MSI 状态和 DNA 修复蛋白表达谱。
Int J Cancer. 2012 Oct 15;131(8):1790-9. doi: 10.1002/ijc.27454. Epub 2012 Mar 14.
10
KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer.KRAS或BRAF突变状态是预测卵巢癌对MEK抑制敏感性的有用指标。
Br J Cancer. 2008 Dec 16;99(12):2020-8. doi: 10.1038/sj.bjc.6604783. Epub 2008 Nov 18.

引用本文的文献

1
Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells.拉帕替尼可使HER2信号传导失调，并损害人葡萄膜黑色素瘤细胞的活力。
J Cancer. 2023 Oct 16;14(18):3477-3495. doi: 10.7150/jca.88446. eCollection 2023.
2
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry.VE-钙黏蛋白调节β-连环蛋白/TCF-4 以增强血管生成拟态。
Cell Death Dis. 2023 Feb 17;14(2):135. doi: 10.1038/s41419-023-05666-7.
3
PARP inhibition promotes endothelial-like traits in melanoma cells and modulates pericyte coverage dynamics during vasculogenic mimicry.
PARP 抑制剂促进黑色素瘤细胞呈现内皮样特征，并调节血管生成拟态过程中的周细胞覆盖动力学。
J Pathol. 2023 Mar;259(3):318-330. doi: 10.1002/path.6043. Epub 2023 Jan 4.
4
Palmitoylation of GNAQ/11 is critical for tumor cell proliferation and survival in GNAQ/11-mutant uveal melanoma.GNAQ/11 的棕榈酰化对于 GNAQ/11 突变的葡萄膜黑素瘤中的肿瘤细胞增殖和存活至关重要。
Front Med. 2022 Oct;16(5):784-798. doi: 10.1007/s11684-021-0911-0. Epub 2022 Aug 23.
5
Animal Models of Uveal Melanoma.葡萄膜黑色素瘤的动物模型
Ann Eye Sci. 2022 Mar;7. doi: 10.21037/aes-21-30. Epub 2022 Mar 15.
6
Relevance of BRAF Subcellular Localization and Its Interaction with and Mutations in Skin Melanoma.BRAF 亚细胞定位及其与 和 突变在皮肤黑色素瘤中的相关性。
Int J Mol Sci. 2021 Nov 3;22(21):11918. doi: 10.3390/ijms222111918.
7
TFPI2 Promotes Perivascular Migration in an Angiotropism Model of Melanoma.TFPI2在黑色素瘤的向血管性模型中促进血管周围迁移。
Front Oncol. 2021 Jun 24;11:662434. doi: 10.3389/fonc.2021.662434. eCollection 2021.
8
The Role of Non-Coding RNAs in Uveal Melanoma.非编码RNA在葡萄膜黑色素瘤中的作用。
Cancers (Basel). 2020 Oct 12;12(10):2944. doi: 10.3390/cancers12102944.
9
Mouse models of uveal melanoma: Strengths, weaknesses, and future directions.葡萄膜黑色素瘤的小鼠模型：优势、劣势及未来方向。
Pigment Cell Melanoma Res. 2020 Mar;33(2):264-278. doi: 10.1111/pcmr.12853. Epub 2020 Jan 22.
10
Anticancer response to disulfiram may be enhanced by co-treatment with MEK inhibitor or oxaliplatin: modulation by tetrathiomolybdate, KRAS/BRAF mutations and c-MYC/p53 status.与MEK抑制剂或奥沙利铂联合治疗可能增强双硫仑的抗癌反应：四硫代钼酸盐、KRAS/BRAF突变及c-MYC/p53状态的调节作用
Ecancermedicalscience. 2019 Jan 8;13:890. doi: 10.3332/ecancer.2019.890. eCollection 2019.